SCHEMBL4496895

SCHEMBL4496895

CC(=O)N(CC(=O)N(C)C)c1ccc(N)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
CYP3A4 P08684 3/20 0.41
MAPK1 P28482 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
TP53 P04637 1/20 0.41
ALOX15 P16050 1/20 0.41
PSMD14 O00487 1/20 0.37
TSHR P16473 1/20 0.37
RECQL P46063 1/20 0.37
GFER P55789 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LMNA P02545 1/20 0.36
CYP1A2 P05177 1/20 0.36
MAOA P21397 1/20 0.36
PHLPP2 Q6ZVD8 1/20 0.35
CYP2D6 P10635 1/20 0.34
OPRK1 P41145 1/20 0.34
TSPO P30536 1/20 0.34
PPIB P23284 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylacetylglycine Dimethylamide SCHEMBL6056919 0.82 ALDH1A1 (0.49) ALDH1A1CYP3A4TP53TSHRL3MBTL1
SCHEMBL9800457 0.82 MLYCD (0.40) ALDH1A1CYP3A4MAPK1TDP1TP53
SCHEMBL30278608 0.80 TSPO (0.48) ALDH1A1CYP3A4MAPK1TP53TSHR
SCHEMBL30352496 0.79 ALDH1A1 (0.52) ALDH1A1MAPK1TDP1LMNACYP1A2
SCHEMBL5626939 0.79 LMNA (0.47) ALDH1A1CYP3A4MAPK1TDP1ALOX15
SCHEMBL780471 0.78 ALDH1A1 (0.52) ALDH1A1CYP3A4MAPK1TDP1TP53
SCHEMBL3148140 0.78 ALDH1A1 (0.49) ALDH1A1CYP3A4MAPK1TDP1TSHR
SCHEMBL3142097 0.77 PHLPP2 (0.46) ALDH1A1CYP3A4MAPK1TDP1TP53
SCHEMBL30065200 0.76 TSPO (0.51) ALDH1A1TP53LMNATSPOSMN1; SMN2
SCHEMBL5627354 0.76 CYP3A4 (0.41) ALDH1A1CYP3A4MAPK1TDP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4622986-A1 BORONIC ACID AND BORONATE COMPOSITIONS AND METHODS Elima Therapeutics, Inc. (US) 2025-10-01 EP disclosed
WO-2024112705-A1 BORONIC ACID AND BORONATE COMPOSITIONS AND METHODS ELIMA THERAPEUTICS, INC. (US) 2024-05-30 WO disclosed
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 US disclosed
EP-1527046-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-05-04 EP disclosed
WO-2004009546-A1 INDOLINE DERIVATIVES SUBSTITUTED IN POSITION 6, PRODUCTION AND USE THEREOF AS MEDICAMENTS BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-01-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR ALDH1A1 2036/4885CYP3A4 441/4885MAPK1 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.